export interface InsightArticle {
  id: number | string;
  title: string;
  slug: string;
  blog_image: string;
  author_name: string;
  author_title: string;
  author_image?: string;
  read_time: string;
  created_at: string;
  updated_at?: string;
  division: string;
  status: string;
  excerpt: string;
  content: string;
}

export const STATIC_INSIGHTS: InsightArticle[] = [
  {
    id: 'reducing-batch-to-batch-variation-lateral-flow-assays',
    title: 'Reducing Batch-to-Batch Variation in Lateral Flow Assays: The Role of Recombinant Antigen Quality',
    slug: 'reducing-batch-to-batch-variation-lateral-flow-assays',
    blog_image: '/images/insights/lateral-flow-variation-antigen-quality.webp',
    author_name: 'Dr. S. K. Narayanan',
    author_title: 'Head of Protein Biochemistry & Diagnostic R&D, SMD Life Sciences',
    author_image: '/images/team/scientist.svg',
    read_time: '14 min read',
    created_at: '2026-09-24T09:00:00+05:30',
    updated_at: '2026-09-24T09:00:00+05:30',
    division: 'biotech',
    status: 'published',
    excerpt: 'A comprehensive technical guide for IVD kit manufacturers on how recombinant antigen purity, conformational integrity, and carrier-free formulations eliminate lot-to-lot test line variation in rapid diagnostic assays.',
    content: `
<div class="space-y-8 text-slate-700 leading-relaxed text-base">

  <!-- Executive Summary Card -->
  <div class="bg-gradient-to-br from-blue-50 to-indigo-50 border border-blue-200/80 rounded-2xl p-6 sm:p-8 shadow-xs">
    <div class="flex items-center gap-3 mb-4">
      <span class="px-3 py-1 bg-blue-600 text-white text-xs font-bold uppercase tracking-wider rounded-full">Executive Summary</span>
      <span class="text-xs text-blue-700 font-medium">IVD Technical Whitepaper &bull; CLSI EP25 / ISO 13485 Compliant</span>
    </div>
    <h3 class="text-xl sm:text-2xl font-bold text-slate-900 mb-3">
      Why Raw Material Consistency Dictates Rapid Test Commercial Success
    </h3>
    <p class="text-slate-700 mb-4">
      In lateral flow immunoassays (LFIA), analytical sensitivity and clinical specificity are determined at the solid-liquid interface of the nitrocellulose membrane and the conjugate release pad. When diagnostic test kit manufacturers experience shifting limits of detection (LoD), fluctuating line intensities, or false-positive ghost bands, the root cause is almost invariably traceable to <strong>lot-to-lot variability in the raw biological reagents</strong>.
    </p>
    <p class="text-slate-700">
      This technical whitepaper examines the biochemical mechanisms linking recombinant antigen quality to lateral flow assay performance. We present practical protocols for incoming lot qualification, analytical criteria for Certificate of Analysis (COA) verification, and an operational roadmap for transitioning from variable native extracts to high-fidelity recombinant antigens manufactured under controlled bioreactor conditions in India.
    </p>
  </div>

  <!-- Key Findings Table -->
  <div class="my-8">
    <h2 class="text-2xl sm:text-3xl font-bold text-slate-900 mb-4">Critical Quality Attributes (CQAs) Affecting Assay Performance</h2>
    <p class="text-slate-600 mb-4">
      Each biochemical parameter of an antigen directly translates into an observable physical outcome on the nitrocellulose test strip.
    </p>
    <div class="overflow-x-auto rounded-xl border border-slate-200 shadow-xs">
      <table class="w-full text-left border-collapse text-sm">
        <thead class="bg-slate-100/80 text-slate-900 font-semibold border-b border-slate-200">
          <tr>
            <th class="p-4">Critical Quality Attribute</th>
            <th class="p-4">Assay Impact on Lateral Flow Strip</th>
            <th class="p-4">Target Analytical Benchmark</th>
            <th class="p-4">Recommended Testing Method</th>
          </tr>
        </thead>
        <tbody class="divide-y divide-slate-200">
          <tr class="hover:bg-slate-50/50">
            <td class="p-4 font-semibold text-slate-900">Antigen Purity</td>
            <td class="p-4 text-slate-600">Elevated background noise, non-specific binding, false positives</td>
            <td class="p-4 text-emerald-700 font-medium">&ge;95% monomeric purity</td>
            <td class="p-4 text-slate-600">SDS-PAGE (reducing &amp; non-reducing) + RP-HPLC</td>
          </tr>
          <tr class="hover:bg-slate-50/50">
            <td class="p-4 font-semibold text-slate-900">Protein Folding &amp; Conformation</td>
            <td class="p-4 text-slate-600">Loss of epitope accessibility, reduced affinity to detector conjugate</td>
            <td class="p-4 text-emerald-700 font-medium">Native-like secondary structure</td>
            <td class="p-4 text-slate-600">Circular Dichroism (CD) &amp; Functional ELISA Binding</td>
          </tr>
          <tr class="hover:bg-slate-50/50">
            <td class="p-4 font-semibold text-slate-900">Soluble Aggregates</td>
            <td class="p-4 text-slate-600">Nitrocellulose pore clogging, streaking, delayed sample flow rate</td>
            <td class="p-4 text-emerald-700 font-medium">&lt;3% aggregate fraction</td>
            <td class="p-4 text-slate-600">Size Exclusion Chromatography (SEC-HPLC)</td>
          </tr>
          <tr class="hover:bg-slate-50/50">
            <td class="p-4 font-semibold text-slate-900">Host Cell Protein (HCP)</td>
            <td class="p-4 text-slate-600">Unpredictable cross-reactivity with human patient sera</td>
            <td class="p-4 text-emerald-700 font-medium">&lt;100 ppm (&lt;0.01%)</td>
            <td class="p-4 text-slate-600">Host-specific ELISA / Western Blot Residual Screening</td>
          </tr>
          <tr class="hover:bg-slate-50/50">
            <td class="p-4 font-semibold text-slate-900">Buffer Matrix &amp; Preservatives</td>
            <td class="p-4 text-slate-600">Inhibition of passive gold adsorption, particle flocculation</td>
            <td class="p-4 text-emerald-700 font-medium">Carrier-free (BSA-free, azide-free)</td>
            <td class="p-4 text-slate-600">Defined formulation: 10 mM PBS / Tris, pH 7.4</td>
          </tr>
        </tbody>
      </table>
    </div>
  </div>

  <!-- Section 1: The Anatomy of Assay Drift -->
  <div class="my-8">
    <h2 class="text-2xl sm:text-3xl font-bold text-slate-900 mb-4">1. The Anatomy of Assay Drift &amp; Inconsistency</h2>
    <p class="mb-4">
      Lateral flow immunoassays are deceptively simple in user execution, yet physically complex in fluidic and molecular behavior. A standard diagnostic test involves moving a capillary sample volume (typically 10&ndash;100 &mu;L of whole blood, serum, or plasma) across four interconnected porous matrices: the sample pad, conjugate release pad, nitrocellulose membrane, and absorbent wick.
    </p>
    <p class="mb-4">
      At the test line, the immobilized capture reagent must bind analyte-conjugate complexes within a transit window lasting between <strong>30 to 180 seconds</strong>. The kinetics of this reaction operate at nanomolar or picomolar concentrations:
    </p>
    <div class="bg-slate-100 rounded-xl p-5 my-4 font-mono text-sm border-l-4 border-blue-600 text-slate-800">
      Flow Rate Equilibrium: [Capture Antigen] + [Antibody-Gold Conjugate] &hArr; [Sandwich Complex] (k<sub>on</sub> / k<sub>off</sub>)
    </div>
    <p class="mb-4">
      If a new incoming antigen batch has a 10% lower active epitope density due to misfolding or partial cleavage, the association rate (k<sub>on</sub>) decreases. Under rapid capillary flow conditions where contact time is strictly limited, this fractional drop causes a dramatic loss of visual signal on the test line. To the end clinician or laboratory technician, this translates to a <strong>false negative result</strong> at low clinical titers.
    </p>
  </div>

  <!-- Contextual Link Box 1: Recombinant Antigens -->
  <div class="p-5 my-6 rounded-xl bg-blue-50/60 border border-blue-200 flex flex-col sm:flex-row sm:items-center justify-between gap-4">
    <div>
      <h4 class="font-bold text-slate-900 text-base">Looking for Batch-Tested Recombinant Antigens?</h4>
      <p class="text-sm text-slate-600">Explore SMD Life Sciences' catalog of recombinant antigens engineered specifically for rapid diagnostic test lines.</p>
    </div>
    <a href="/recombinant-antigens" class="inline-flex items-center justify-center px-4 py-2 bg-blue-600 hover:bg-blue-700 text-white font-medium text-sm rounded-lg transition-colors whitespace-nowrap">
      View Recombinant Antigens &rarr;
    </a>
  </div>

  <!-- Section 2: Recombinant vs Native Comparison -->
  <div class="my-8">
    <h2 class="text-2xl sm:text-3xl font-bold text-slate-900 mb-4">2. Recombinant vs. Native Antigens: An Analytical Comparison for IVD Teams</h2>
    <p class="mb-4">
      Historically, diagnostic assays relied heavily on native antigens extracted directly from cultured pathogens, infected cell lysates, or biological fluids. While native antigens retain natural post-translational modifications, their production exhibits inherent biological variability that conflicts with modern ISO 13485 and regulatory prequalification standards.
    </p>

    <div class="overflow-x-auto rounded-xl border border-slate-200 shadow-xs my-6">
      <table class="w-full text-left border-collapse text-sm">
        <thead class="bg-slate-100/80 text-slate-900 font-semibold border-b border-slate-200">
          <tr>
            <th class="p-4">Operational Dimension</th>
            <th class="p-4 text-blue-900">Recombinant Antigens (SMD Standard)</th>
            <th class="p-4 text-slate-600">Native / Tissue-Derived Extracts</th>
          </tr>
        </thead>
        <tbody class="divide-y divide-slate-200">
          <tr class="hover:bg-slate-50/50">
            <td class="p-4 font-semibold text-slate-900">Lot-to-Lot Consistency</td>
            <td class="p-4 text-emerald-700 font-medium">Exceptional (&plusmn;5% batch CV via defined bioreactor fermentation)</td>
            <td class="p-4 text-rose-700">Poor (20&ndash;40% batch variation across biological harvest cycles)</td>
          </tr>
          <tr class="hover:bg-slate-50/50">
            <td class="p-4 font-semibold text-slate-900">Scalability (mg to kg)</td>
            <td class="p-4 text-slate-700">Predictable linear scale-up in 50L&ndash;500L fermenters</td>
            <td class="p-4 text-slate-700">Limited by availability of infectious source materials</td>
          </tr>
          <tr class="hover:bg-slate-50/50">
            <td class="p-4 font-semibold text-slate-900">Epitope Customization</td>
            <td class="p-4 text-slate-700">Gene synthesis enables truncation of cross-reactive domains and chimeric fusions</td>
            <td class="p-4 text-slate-700">Fixed to natural wild-type sequence; high cross-reactivity risk</td>
          </tr>
          <tr class="hover:bg-slate-50/50">
            <td class="p-4 font-semibold text-slate-900">Biosafety &amp; Handling</td>
            <td class="p-4 text-slate-700">Non-infectious, standardized BSL-1 handling</td>
            <td class="p-4 text-slate-700">Infectious risk requires rigorous viral inactivation certification</td>
          </tr>
          <tr class="hover:bg-slate-50/50">
            <td class="p-4 font-semibold text-slate-900">Downstream Purity</td>
            <td class="p-4 text-slate-700">&ge;95% single-step or tandem affinity chromatography</td>
            <td class="p-4 text-slate-700">Frequently contaminated with host lipid residues and cellular debris</td>
          </tr>
        </tbody>
      </table>
    </div>
  </div>

  <!-- Callout Box: SMD Engineering Perspective -->
  <div class="my-8 bg-slate-900 text-white rounded-2xl p-6 sm:p-8 relative overflow-hidden shadow-md">
    <div class="absolute -right-10 -bottom-10 w-48 h-48 bg-blue-600/20 rounded-full blur-2xl pointer-events-none"></div>
    <div class="flex items-center gap-2 text-blue-400 text-xs font-bold uppercase tracking-widest mb-3">
      <svg class="w-4 h-4" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 10V3L4 14h7v7l9-11h-7z" /></svg>
      The SMD Life Sciences Engineering Perspective
    </div>
    <h3 class="text-xl font-bold text-white mb-3">Purity Without Functional Fidelity is a Diagnostic Trap</h3>
    <p class="text-slate-300 text-sm sm:text-base leading-relaxed mb-4">
      &ldquo;Many diagnostic R&amp;D teams rely solely on a supplier's single-lane Coomassie SDS-PAGE scan indicating &gt;95% purity. However, a denatured gel tells you nothing about whether the protein exists as an active monomer or as a high-molecular-weight soluble aggregate that will precipitate upon drying on nitrocellulose.
    </p>
    <p class="text-slate-300 text-sm sm:text-base leading-relaxed">
      In our Bangalore biomanufacturing facility, we evaluate every recombinant antigen lot through <strong>orthogonal SEC-HPLC profiling and real-time colloidal gold conjugate stability</strong>. For high-volume rapid test lines like Dengue NS1, Malaria Pf/Pv, and Cardiac Troponin I, conformational stability and amine accessibility are the true determinants of zero lot-to-lot drift.&rdquo;
    </p>
  </div>

  <!-- Section 3: COA Audit Matrix -->
  <div class="my-8">
    <h2 class="text-2xl sm:text-3xl font-bold text-slate-900 mb-4">3. Critical Specifications IVD Manufacturers Must Demand (COA Audit)</h2>
    <p class="mb-4">
      When procuring recombinant antigens or antibodies for commercial IVD kit production, procurement managers and QA auditors must look beyond basic concentration values. A compliant Certificate of Analysis (COA) must provide quantitative results for the following critical parameters:
    </p>

    <div class="grid grid-cols-1 md:grid-cols-2 gap-4 my-6">
      <div class="border border-slate-200 rounded-xl p-5 bg-white shadow-xs">
        <h4 class="font-bold text-slate-900 text-base mb-2 flex items-center gap-2">
          <span class="w-2 h-2 rounded-full bg-blue-600"></span>
          Physical &amp; Biochemical Identity
        </h4>
        <ul class="text-sm text-slate-600 space-y-2">
          <li><strong>Molecular Weight:</strong> Intact Mass Spectrometry (MALDI-TOF / ESI-MS) matching theoretical sequence within &plusmn;5 Da.</li>
          <li><strong>Purity (Denatured):</strong> &ge;95% by SDS-PAGE under both reducing (with DTT/&beta;-ME) and non-reducing conditions.</li>
          <li><strong>Monomer Fraction (Native):</strong> &ge;95% monomer species quantified via Analytical SEC-HPLC.</li>
        </ul>
      </div>

      <div class="border border-slate-200 rounded-xl p-5 bg-white shadow-xs">
        <h4 class="font-bold text-slate-900 text-base mb-2 flex items-center gap-2">
          <span class="w-2 h-2 rounded-full bg-indigo-600"></span>
          Residual Contaminants &amp; Buffer Matrix
        </h4>
        <ul class="text-sm text-slate-600 space-y-2">
          <li><strong>Host Cell Contamination:</strong> Residual host-cell protein &lt;100 ppm; host-cell DNA &lt;10 ng/mg.</li>
          <li><strong>Bioburden &amp; Endotoxin:</strong> &lt;0.1 EU/&mu;g for endotoxin; zero microbial contamination on 14-day broth culture.</li>
          <li><strong>Carrier Formulation:</strong> Absolutely free of Bovine Serum Albumin (BSA), gelatin, and sodium azide (&gt;0.02% azide inhibits gold conjugation).</li>
        </ul>
      </div>
    </div>
  </div>

  <!-- Contextual Link Box 2: IVD Raw Materials -->
  <div class="p-5 my-6 rounded-xl bg-indigo-50/60 border border-indigo-200 flex flex-col sm:flex-row sm:items-center justify-between gap-4">
    <div>
      <h4 class="font-bold text-slate-900 text-base">Need Indigenous IVD Raw Materials with Complete COA Traceability?</h4>
      <p class="text-sm text-slate-600">Discover our full range of raw materials for lateral flow and ELISA kits manufactured in Bangalore.</p>
    </div>
    <a href="/ivd-raw-materials" class="inline-flex items-center justify-center px-4 py-2 bg-indigo-600 hover:bg-indigo-700 text-white font-medium text-sm rounded-lg transition-colors whitespace-nowrap">
      Explore IVD Raw Materials &rarr;
    </a>
  </div>

  <!-- Section 4: 8-Step Lot Qualification Workflow -->
  <div class="my-8">
    <h2 class="text-2xl sm:text-3xl font-bold text-slate-900 mb-4">4. An 8-Step Incoming Lot Qualification Workflow for IVD Manufacturers</h2>
    <p class="mb-4">
      To prevent defective or drifting lots from reaching your commercial cassette assembly line, follow this standardized 8-step qualification SOP developed in accordance with CLSI EP25 guidelines:
    </p>

    <div class="space-y-4 my-6">
      <div class="flex gap-4 p-4 rounded-xl border border-slate-200 bg-white">
        <div class="w-8 h-8 rounded-full bg-blue-100 text-blue-700 font-bold text-sm flex items-center justify-center shrink-0">1</div>
        <div>
          <h4 class="font-bold text-slate-900 text-base">Define Target Analytical Sensitivity (LoD)</h4>
          <p class="text-sm text-slate-600 mt-1">Establish quantitative cutoff optical density values on strip reader hardware using calibrated human reference panels.</p>
        </div>
      </div>

      <div class="flex gap-4 p-4 rounded-xl border border-slate-200 bg-white">
        <div class="w-8 h-8 rounded-full bg-blue-100 text-blue-700 font-bold text-sm flex items-center justify-center shrink-0">2</div>
        <div>
          <h4 class="font-bold text-slate-900 text-base">Request Pre-Shipment Representative Samples</h4>
          <p class="text-sm text-slate-600 mt-1">Always test a 0.5&ndash;1.0 mg pre-shipment pilot aliquot harvested from the exact production batch that will be bottled for your commercial order.</p>
        </div>
      </div>

      <div class="flex gap-4 p-4 rounded-xl border border-slate-200 bg-white">
        <div class="w-8 h-8 rounded-full bg-blue-100 text-blue-700 font-bold text-sm flex items-center justify-center shrink-0">3</div>
        <div>
          <h4 class="font-bold text-slate-900 text-base">Perform In-House SDS-PAGE &amp; A280 Spectrophotometry</h4>
          <p class="text-sm text-slate-600 mt-1">Verify protein concentration using the lot-specific extinction coefficient ($E^{0.1\%}$) and check for low-molecular-weight degradation bands.</p>
        </div>
      </div>

      <div class="flex gap-4 p-4 rounded-xl border border-slate-200 bg-white">
        <div class="w-8 h-8 rounded-full bg-blue-100 text-blue-700 font-bold text-sm flex items-center justify-center shrink-0">4</div>
        <div>
          <h4 class="font-bold text-slate-900 text-base">Pilot Gold/Latex Conjugation Evaluation</h4>
          <p class="text-sm text-slate-600 mt-1">Perform pH titration and minimum protective protein concentration (salt flocculation test) with 40 nm colloidal gold nanoparticles.</p>
        </div>
      </div>

      <div class="flex gap-4 p-4 rounded-xl border border-slate-200 bg-white">
        <div class="w-8 h-8 rounded-full bg-blue-100 text-blue-700 font-bold text-sm flex items-center justify-center shrink-0">5</div>
        <div>
          <h4 class="font-bold text-slate-900 text-base">Head-to-Head Nitrocellulose Striping</h4>
          <p class="text-sm text-slate-600 mt-1">Dispense the candidate lot alongside your current approved reference lot on identical nitrocellulose rolls at 0.8&ndash;1.2 &mu;L/cm.</p>
        </div>
      </div>

      <div class="flex gap-4 p-4 rounded-xl border border-slate-200 bg-white">
        <div class="w-8 h-8 rounded-full bg-blue-100 text-blue-700 font-bold text-sm flex items-center justify-center shrink-0">6</div>
        <div>
          <h4 class="font-bold text-slate-900 text-base">Accelerated Thermal Stress Testing (45&deg;C Protocol)</h4>
          <p class="text-sm text-slate-600 mt-1">Incubate assembled test strips with desiccant at 45&deg;C for 14 days (predictive of 12 months at room temperature) and monitor line intensity degradation.</p>
        </div>
      </div>

      <div class="flex gap-4 p-4 rounded-xl border border-slate-200 bg-white">
        <div class="w-8 h-8 rounded-full bg-blue-100 text-blue-700 font-bold text-sm flex items-center justify-center shrink-0">7</div>
        <div>
          <h4 class="font-bold text-slate-900 text-base">Specificity &amp; Cross-Reactivity Panel Testing</h4>
          <p class="text-sm text-slate-600 mt-1">Run at least 20 clinical negative samples and interfering substances (hemoglobin, lipids, bilirubin, rheumatoid factor) to confirm zero ghost lines.</p>
        </div>
      </div>

      <div class="flex gap-4 p-4 rounded-xl border border-slate-200 bg-white">
        <div class="w-8 h-8 rounded-full bg-blue-100 text-blue-700 font-bold text-sm flex items-center justify-center shrink-0">8</div>
        <div>
          <h4 class="font-bold text-slate-900 text-base">Dual-Lot Overlap Reservation Agreement</h4>
          <p class="text-sm text-slate-600 mt-1">Sign off on the commercial batch and establish a 3&ndash;6 month inventory reservation agreement with the manufacturer before depleting current stock.</p>
        </div>
      </div>
    </div>
  </div>

  <!-- Section 5: Diagnostic CDMO Services Bridge -->
  <div class="my-8">
    <h2 class="text-2xl sm:text-3xl font-bold text-slate-900 mb-4">5. When Off-the-Shelf Antigens Fail: Custom Recombinant Engineering &amp; CDMO</h2>
    <p class="mb-4">
      In many diagnostic assay development programs, catalog proteins do not meet target sensitivity criteria. Common hurdles include:
    </p>
    <ul class="list-disc pl-6 space-y-2 mb-4 text-slate-600">
      <li>Homology cross-reactivity (e.g., Dengue NS1 antibodies binding Zika virus or Chikungunya surface antigens).</li>
      <li>Hydrophobic aggregation when drying onto nitrocellulose solid phase.</li>
      <li>Low expression yield in standard <em>E. coli</em> vectors necessitating eukaryotic expression in <em>Pichia pastoris</em> or Mammalian (CHO/HEK293) platforms.</li>
    </ul>
    <p class="mb-4">
      This is where partnering with an end-to-end <strong>Diagnostic CDMO</strong> provides a strategic advantage. Instead of wrestling with off-the-shelf catalog mismatches, IVD developers can commission custom antigen expression, monoclonal antibody pairing, and lateral flow contract manufacturing under one roof in Bangalore.
    </p>
  </div>

  <!-- Contextual Link Box 3: Diagnostic CDMO -->
  <div class="p-6 my-8 rounded-2xl bg-gradient-to-r from-teal-50 to-blue-50 border border-teal-200/80 shadow-xs">
    <div class="flex flex-col md:flex-row md:items-center justify-between gap-4">
      <div>
        <span class="text-xs font-bold text-teal-700 uppercase tracking-widest">End-to-End Assay Outsourcing</span>
        <h3 class="text-lg sm:text-xl font-bold text-slate-900 mt-1">Accelerate Your Diagnostic Kit Development with SMD Life Sciences</h3>
        <p class="text-sm text-slate-600 mt-1">From gene synthesis and pilot antigen fermentation to lateral flow strip manufacturing, contract assembly, and CDSCO/ISO 13485 regulatory dossiers.</p>
      </div>
      <a href="/diagnostic-cdmo" class="inline-flex items-center justify-center px-5 py-2.5 bg-teal-600 hover:bg-teal-700 text-white font-semibold text-sm rounded-xl transition-all shadow-xs shrink-0">
        Explore Diagnostic CDMO Services &rarr;
      </a>
    </div>
  </div>

  <!-- Section 6: Supplier Checklist -->
  <div class="my-8">
    <h2 class="text-2xl sm:text-3xl font-bold text-slate-900 mb-4">6. Supplier Qualification Checklist for Indian IVD Procurement Teams</h2>
    <p class="mb-4">
      Before signing long-term raw material supply contracts, procurement officers should verify that the prospective antigen manufacturer meets these 8 operational criteria:
    </p>

    <div class="space-y-3 my-6">
      <div class="flex items-start gap-3 p-3.5 rounded-lg border border-slate-200 bg-white">
        <svg class="w-5 h-5 text-emerald-600 shrink-0 mt-0.5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7" /></svg>
        <span class="text-sm text-slate-700"><strong>Batch Size Scaling:</strong> Ability to provide identical pilot test lots (1&ndash;10 mg) and production batches (100 mg to 50+ grams) from the same master cell bank.</span>
      </div>
      <div class="flex items-start gap-3 p-3.5 rounded-lg border border-slate-200 bg-white">
        <svg class="w-5 h-5 text-emerald-600 shrink-0 mt-0.5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7" /></svg>
        <span class="text-sm text-slate-700"><strong>Local Bangalore Biomanufacturing:</strong> Indigenous domestic production avoids international customs hold-ups, dry-ice evaporation, and foreign currency volatility.</span>
      </div>
      <div class="flex items-start gap-3 p-3.5 rounded-lg border border-slate-200 bg-white">
        <svg class="w-5 h-5 text-emerald-600 shrink-0 mt-0.5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7" /></svg>
        <span class="text-sm text-slate-700"><strong>Lot Reservation Programs:</strong> Willingness to warehouse validated reserve lots for up to 12 months with guaranteed supply agreements.</span>
      </div>
      <div class="flex items-start gap-3 p-3.5 rounded-lg border border-slate-200 bg-white">
        <svg class="w-5 h-5 text-emerald-600 shrink-0 mt-0.5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7" /></svg>
        <span class="text-sm text-slate-700"><strong>Direct Scientific Access:</strong> R&amp;D team can interface directly with the protein biochemists who cloned and purified the reagent, rather than communicating through third-party catalog resellers.</span>
      </div>
      <div class="flex items-start gap-3 p-3.5 rounded-lg border border-slate-200 bg-white">
        <svg class="w-5 h-5 text-emerald-600 shrink-0 mt-0.5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7" /></svg>
        <span class="text-sm text-slate-700"><strong>ISO 13485 &amp; GMP Traceability:</strong> Complete documentation of fermentation, chromatography, and endotoxin monitoring for CDSCO device file submissions.</span>
      </div>
    </div>
  </div>

  <!-- Frequently Asked Questions -->
  <div class="my-8">
    <h2 class="text-2xl sm:text-3xl font-bold text-slate-900 mb-6">Frequently Asked Questions (Technical &amp; Commercial)</h2>
    <div class="space-y-4">
      <details class="group bg-white rounded-xl border border-slate-200 p-5 open:bg-slate-50/50 transition-colors">
        <summary class="font-bold text-slate-900 cursor-pointer list-none flex justify-between items-center text-base">
          <span>What is the single most common cause of test line fading between antigen batches?</span>
          <span class="text-blue-600 group-open:rotate-180 transition-transform">&darr;</span>
        </summary>
        <p class="mt-3 text-sm text-slate-600 leading-relaxed">
          The most prevalent cause is partial degradation or subtle conformational folding changes in the recombinant protein that affect the active epitope density. Even when total protein concentration by A280 is identical, if 20% of the antigen has unfolded or formed soluble aggregates, the effective binding kinetics at the test line drop significantly under rapid capillary flow conditions.
        </p>
      </details>

      <details class="group bg-white rounded-xl border border-slate-200 p-5 open:bg-slate-50/50 transition-colors">
        <summary class="font-bold text-slate-900 cursor-pointer list-none flex justify-between items-center text-base">
          <span>Why must antigens for colloidal gold conjugation be strictly carrier-free?</span>
          <span class="text-blue-600 group-open:rotate-180 transition-transform">&darr;</span>
        </summary>
        <p class="mt-3 text-sm text-slate-600 leading-relaxed">
          Carrier proteins like Bovine Serum Albumin (BSA) or gelatin compete directly with the target antibody or antigen for binding sites on the colloidal gold nanoparticle surface. Because albumin has high surface affinity, even trace amounts of BSA will saturate the gold particles, preventing target molecule adsorption and leading to total conjugate failure.
        </p>
      </details>

      <details class="group bg-white rounded-xl border border-slate-200 p-5 open:bg-slate-50/50 transition-colors">
        <summary class="font-bold text-slate-900 cursor-pointer list-none flex justify-between items-center text-base">
          <span>Can SMD Life Sciences supply customized evaluation samples for lateral flow pilots?</span>
          <span class="text-blue-600 group-open:rotate-180 transition-transform">&darr;</span>
        </summary>
        <p class="mt-3 text-sm text-slate-600 leading-relaxed">
          Yes. SMD Life Sciences provides qualification sample vials (0.5 mg to 2.0 mg) accompanied by comprehensive lot-specific Certificates of Analysis (COA), SDS-PAGE scans, and reconstitution guidance for lateral flow strip dispensing and ELISA plate coating.
        </p>
      </details>

      <details class="group bg-white rounded-xl border border-slate-200 p-5 open:bg-slate-50/50 transition-colors">
        <summary class="font-bold text-slate-900 cursor-pointer list-none flex justify-between items-center text-base">
          <span>How does domestic Bangalore sourcing reduce overall kit manufacturing risk?</span>
          <span class="text-blue-600 group-open:rotate-180 transition-transform">&darr;</span>
        </summary>
        <p class="mt-3 text-sm text-slate-600 leading-relaxed">
          Importing critical biological raw materials into India exposes diagnostic manufacturers to cold-chain breaches during customs clearance delays at major ports, high import duties (15&ndash;28%), and currency fluctuations. Sourcing directly from SMD Life Sciences' Bangalore facility ensures validated 24&ndash;48 hour dry-ice transit across India and uninterrupted lot continuity.
        </p>
      </details>
    </div>
  </div>

  <!-- References & Citations -->
  <div class="my-8 pt-6 border-t border-slate-200 text-xs text-slate-500 space-y-2">
    <h4 class="font-bold text-slate-700 uppercase tracking-wider text-xs mb-2">Scientific Citations &amp; Regulatory Guidelines</h4>
    <p>1. Clinical and Laboratory Standards Institute (CLSI). <em>Evaluation of Stability of In Vitro Diagnostic Reagents; Approved Guideline</em>. CLSI document EP25-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2009.</p>
    <p>2. Posthuma-Trumpie GA, Korf J, van Amerongen A. <em>Lateral flow (immuno)assays: principles, recent developments and applications</em>. Analytical and Bioanalytical Chemistry. 2009; 393(2):569-582.</p>
    <p>3. International Organization for Standardization (ISO). <em>Medical devices &mdash; Quality management systems &mdash; Requirements for regulatory purposes</em>. ISO 13485:2016.</p>
    <p>4. World Health Organization (WHO). <em>Prequalification of In Vitro Diagnostics: Technical Guidance Series for WHO Prequalification Diagnostic Assessment</em>. Geneva: WHO; 2017.</p>
  </div>

  <!-- Conversion Section / RFQ Matrix -->
  <div class="my-10 bg-gradient-to-br from-blue-900 via-indigo-900 to-slate-900 text-white rounded-3xl p-8 sm:p-10 shadow-xl">
    <div class="max-w-2xl">
      <span class="px-3 py-1 bg-blue-500/20 text-blue-300 border border-blue-400/30 rounded-full text-xs font-semibold uppercase tracking-wider">
        Partner with SMD Life Sciences
      </span>
      <h3 class="text-2xl sm:text-3xl font-extrabold text-white mt-4 mb-3">
        Eliminate Lot Variability in Your Diagnostic Assays Today
      </h3>
      <p class="text-slate-300 text-sm sm:text-base leading-relaxed mb-6">
        Request evaluation samples of our recombinant antigens, download batch chromatography profiles, or schedule a technical consultation with our Bangalore protein development team.
      </p>
      <div class="flex flex-wrap gap-4">
        <a href="/contact?subject=Sample+Evaluation+Request" class="px-6 py-3 bg-blue-500 hover:bg-blue-600 text-white font-bold text-sm rounded-xl transition-all shadow-md">
          Request Evaluation Sample Lot
        </a>
        <a href="/recombinant-antigens" class="px-6 py-3 bg-white/10 hover:bg-white/20 text-white border border-white/20 font-bold text-sm rounded-xl transition-all">
          Browse Recombinant Antigens
        </a>
        <a href="/diagnostic-cdmo" class="px-6 py-3 bg-teal-500/20 hover:bg-teal-500/30 text-teal-300 border border-teal-400/30 font-bold text-sm rounded-xl transition-all">
          Diagnostic CDMO Consultation
        </a>
      </div>
    </div>
  </div>

</div>
    `
  }
];

export function getStaticInsightBySlug(slug: string): InsightArticle | undefined {
  const clean = slug.replace(/\.html$/, '');
  return STATIC_INSIGHTS.find((a) => a.slug === clean || a.slug === slug || String(a.id) === clean);
}
